These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Protection of isolated perfused working rat heart from oxidative stress by exogenous L-propionyl carnitine. Ronca G, Ronca F, Yu G, Zucchi R, Bertelli A. Drugs Exp Clin Res; 1992; 18(11-12):475-80. PubMed ID: 1308473 [Abstract] [Full Text] [Related]
3. Carnitine and peripheral arterial disease. Hiatt WR. Ann N Y Acad Sci; 2004 Nov; 1033():92-8. PubMed ID: 15591006 [Abstract] [Full Text] [Related]
4. Propionyl-L-carnitine in Leriche-Fontaine stage II peripheral arterial obstructive disease. Allegra C, Antignani PL, Schachter I, Koverech A, Messano M, Virmani A. Ann Vasc Surg; 2008 Nov; 22(4):552-8. PubMed ID: 18502605 [Abstract] [Full Text] [Related]
8. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review. Ferrari R, Merli E, Cicchitelli G, Mele D, Fucili A, Ceconi C. Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005 [Abstract] [Full Text] [Related]
9. L-propionyl carnitine protects erythrocytes and low density lipoproteins against peroxidation. Bertelli A, Conte A, Ronca G. Drugs Exp Clin Res; 1994 Nov; 20(5):191-7. PubMed ID: 7875055 [Abstract] [Full Text] [Related]
10. Evaluation of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic patients affected by obliterating arteriopathy Leriche stage II. Riccioni C, Sarcinella R, Palermo G, Izzo A, Liguori M, Koverech A, Messano M, Virmani A. Int Angiol; 2008 Jun; 27(3):253-9. PubMed ID: 18506129 [Abstract] [Full Text] [Related]
11. Effects of intravenous and intra-arterial infusions of prostaglandin E1 on canine hindlimb blood flow distribution. Lynch TG, Hobson RW, Barbalinardo JP, Kerr JC. Surgery; 1984 Jul; 96(1):35-41. PubMed ID: 6539953 [Abstract] [Full Text] [Related]
12. L-carnitine and propionyl-L-carnitine improve endothelial dysfunction in spontaneously hypertensive rats: different participation of NO and COX-products. Bueno R, Alvarez de Sotomayor M, Perez-Guerrero C, Gomez-Amores L, Vazquez CM, Herrera MD. Life Sci; 2005 Sep 09; 77(17):2082-97. PubMed ID: 15958269 [Abstract] [Full Text] [Related]
13. The effect of propionyl L-carnitine on skeletal muscle metabolism in renal failure. Thompson CH, Irish AB, Kemp GJ, Taylor DJ, Radda GK. Clin Nephrol; 1997 Jun 09; 47(6):372-8. PubMed ID: 9202867 [Abstract] [Full Text] [Related]
14. Increased flow rate and papaverine increase K+ exchange in perfused rat hind-limb skeletal muscle. Lindinger MI, Hawke TJ. Can J Physiol Pharmacol; 1999 Jul 09; 77(7):536-43. PubMed ID: 10535714 [Abstract] [Full Text] [Related]
16. Size-dependent effects of microspheres on vasoconstrictor-mediated change in oxygen uptake by perfused rat hindlimb. Vincent MA, Rattigan S, Clark MG. Microvasc Res; 2001 Nov 09; 62(3):306-14. PubMed ID: 11678633 [Abstract] [Full Text] [Related]
18. Homeostatic equilibrium of L-carnitine family before and after i.v. administration of propionyl-L-carnitine in humans, dogs and rats. Marzo A, Cardace G, Corbelleta C, Bassani E, Morabito E, Arrigoni Martelli E. Eur J Drug Metab Pharmacokinet; 1991 Nov 09; Spec No 3():357-63. PubMed ID: 1820908 [Abstract] [Full Text] [Related]
19. Cyclosporine-induced lipid peroxidation and propionyl carnitine protective effect. Longoni B, Giovannini L, Migliori M, Bertelli AA, Bertelli A. Int J Tissue React; 1999 Nov 09; 21(1):7-11. PubMed ID: 10463135 [Abstract] [Full Text] [Related]
20. Effects of propionyl-L-carnitine topical irrigation in distal ulcerative colitis: a preliminary report. Gasbarrini G, Mingrone G, Giancaterini A, De Gaetano A, Scarfone A, Capristo E, Calvani M, Caso V, Greco AV. Hepatogastroenterology; 2003 Nov 09; 50(53):1385-9. PubMed ID: 14571743 [Abstract] [Full Text] [Related] Page: [Next] [New Search]